Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569128978> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W1569128978 endingPage "9" @default.
- W1569128978 startingPage "732" @default.
- W1569128978 abstract "The primary objective of this study was to determine if a pharmacist-managed anticoagulation monitoring service (AMS) improved the outcomes of patients receiving warfarin in a family practice setting and was cost effective in treating and preventing thromboembolic disorders. A retrospective chart review was performed on all patients at the University of Florida's Family Practice Residency Program who received warfarin pharmacotherapy between October 1, 1988, and December 15, 1993. The outcomes of patients followed by AMS were compared with those of a control group consisting of patients receiving warfarin but followed only by their physician. Outcomes were evaluated based on the number of thromboembolic and hemorrhagic events, as well as unplanned clinic visits, emergency room visits, and hospital admissions. Cost of hospital admissions, emergency room visits, and participation in the AMS were analyzed. During 28 person-years of treatment, control subjects sustained 12 thromboembolic events (2 pulmonary embolisms, 1 cerebrovascular accident, and 9 deep venous thromboses) and 2 minor and 5 major hemorrhagic events. The study group reported two minor hemorrhagic events during a total of 60 person-years. The control group was 20 times more likely than the study group to experience any event (rate ratio 20, 95% CI 5-87). In addition, hospitalization and emergency room charges indicated an actual cost of $119,074.95 for the control group's events. The cost to this group for 28 person-years of participation in the AMS would have been $5040.00. A potential cost avoidance of $4072.68 per person-year of follow-up may have been possible if these patients had been followed by the AMS. A pharmacist-managed AMS in a family practice setting can result in improved outcomes for patients receiving warfarin and is cost effective." @default.
- W1569128978 created "2016-06-24" @default.
- W1569128978 creator A5013078604 @default.
- W1569128978 creator A5072998249 @default.
- W1569128978 creator A5075968422 @default.
- W1569128978 creator A5077225557 @default.
- W1569128978 date "1995-11-01" @default.
- W1569128978 modified "2023-10-10" @default.
- W1569128978 title "Outcome analysis of a pharmacist-managed anticoagulation service." @default.
- W1569128978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8602380" @default.
- W1569128978 hasPublicationYear "1995" @default.
- W1569128978 type Work @default.
- W1569128978 sameAs 1569128978 @default.
- W1569128978 citedByCount "61" @default.
- W1569128978 countsByYear W15691289782012 @default.
- W1569128978 countsByYear W15691289782013 @default.
- W1569128978 countsByYear W15691289782015 @default.
- W1569128978 countsByYear W15691289782016 @default.
- W1569128978 countsByYear W15691289782017 @default.
- W1569128978 countsByYear W15691289782018 @default.
- W1569128978 countsByYear W15691289782020 @default.
- W1569128978 countsByYear W15691289782021 @default.
- W1569128978 crossrefType "journal-article" @default.
- W1569128978 hasAuthorship W1569128978A5013078604 @default.
- W1569128978 hasAuthorship W1569128978A5072998249 @default.
- W1569128978 hasAuthorship W1569128978A5075968422 @default.
- W1569128978 hasAuthorship W1569128978A5077225557 @default.
- W1569128978 hasConcept C104863432 @default.
- W1569128978 hasConcept C118552586 @default.
- W1569128978 hasConcept C126322002 @default.
- W1569128978 hasConcept C167135981 @default.
- W1569128978 hasConcept C187212893 @default.
- W1569128978 hasConcept C194828623 @default.
- W1569128978 hasConcept C2776301958 @default.
- W1569128978 hasConcept C2779161974 @default.
- W1569128978 hasConcept C2779457091 @default.
- W1569128978 hasConcept C2780724011 @default.
- W1569128978 hasConcept C512399662 @default.
- W1569128978 hasConcept C545542383 @default.
- W1569128978 hasConcept C71924100 @default.
- W1569128978 hasConceptScore W1569128978C104863432 @default.
- W1569128978 hasConceptScore W1569128978C118552586 @default.
- W1569128978 hasConceptScore W1569128978C126322002 @default.
- W1569128978 hasConceptScore W1569128978C167135981 @default.
- W1569128978 hasConceptScore W1569128978C187212893 @default.
- W1569128978 hasConceptScore W1569128978C194828623 @default.
- W1569128978 hasConceptScore W1569128978C2776301958 @default.
- W1569128978 hasConceptScore W1569128978C2779161974 @default.
- W1569128978 hasConceptScore W1569128978C2779457091 @default.
- W1569128978 hasConceptScore W1569128978C2780724011 @default.
- W1569128978 hasConceptScore W1569128978C512399662 @default.
- W1569128978 hasConceptScore W1569128978C545542383 @default.
- W1569128978 hasConceptScore W1569128978C71924100 @default.
- W1569128978 hasIssue "6" @default.
- W1569128978 hasLocation W15691289781 @default.
- W1569128978 hasOpenAccess W1569128978 @default.
- W1569128978 hasPrimaryLocation W15691289781 @default.
- W1569128978 hasRelatedWork W2028663207 @default.
- W1569128978 hasRelatedWork W2041223080 @default.
- W1569128978 hasRelatedWork W2090060319 @default.
- W1569128978 hasRelatedWork W2112678015 @default.
- W1569128978 hasRelatedWork W2507101847 @default.
- W1569128978 hasRelatedWork W2571190148 @default.
- W1569128978 hasRelatedWork W2979886478 @default.
- W1569128978 hasRelatedWork W3087515081 @default.
- W1569128978 hasRelatedWork W3204730624 @default.
- W1569128978 hasRelatedWork W4241335901 @default.
- W1569128978 hasVolume "15" @default.
- W1569128978 isParatext "false" @default.
- W1569128978 isRetracted "false" @default.
- W1569128978 magId "1569128978" @default.
- W1569128978 workType "article" @default.